Zobrazeno 1 - 10
of 276
pro vyhledávání: '"J J, Shuster"'
Autor:
Desmond A. Schatz, Jennifer M Stein, J J Shuster, Michael J. Haller, Michael G. Earing, Douglas W. Theriaque, Farid H. Mahmud, Amir Lerman, Janet H. Silverstein
Publikováno v:
Pediatric Diabetes. 8:193-198
Objectives: To assess the ability of reactive hyperemia–peripheral artery tonometry (RH-PAT) to serve as a surrogate marker of endothelial dysfunction in children with type 1 diabetes (T1D). Research Design and Methods: Forty-four children with T1D
Autor:
S. Sterikoff, Gary R. Erdmann, Bruce Bostrom, Bruce M. Camitta, J J Shuster, G.N. Brockway, Beverly Bell
Publikováno v:
Pediatric Blood & Cancer. 43:105-109
Introduction. Mercaptopurine is an important antimetabolite for treatment of childhood acute lymphoblastic leukemia (ALL). It has been prescribed to be given daily without therapeutic monitoring of drug levels. After first-pass metabolism by hepatic
Autor:
J J Shuster, L. Munoz, Donald H. Mahoney, Bruce M. Camitta, Stuart Toledano, Naomi J. Winick, G. Kiefer, Jeanette Pullen, C P Steuber, Stephen J. Lauer
Publikováno v:
Leukemia. 15:1038-1045
A prospective, randomized multicenter study was performed to evaluate the relative efficacy of two different concepts for early intensive therapy in a randomized trial of children with B-precursor acute lymphoblastic leukemia (ALL) at high risk (HR)
Autor:
Bruce M. Camitta, J J Shuster, Jeanette Pullen, Michael E. Harris, Frederick G. Behm, V. J. Land, Michael J. Borowitz, Andrew J. Carroll
Publikováno v:
Leukemia. 14:1570-1576
Between May 1987 and January 1991, 1354 patients, 1-21 years old, with standard or poor prognosis B-lineage acute lymphocytic leukemia were treated on the Pediatric Oncology Group Study 8602. One thousand three hundred and twenty-three patients enter
Autor:
Sharon B. Murphy, Michael D. Amylon, Michael J. Borowitz, Yaddanapudi Ravindranath, Joanne Kurtzberg, J J Shuster, Bruce M. Camitta, Molly Schwenn, Julio C. Barredo, Michael P. Link, Jeanette Pullen, Joseph H. Laver
Publikováno v:
Leukemia. 14:369-373
Contemporary chemotherapy has significantly improved event-free survival among patients with T cell-lineage acute lymphoblastic leukemia (T-ALL). Unlike B-precursor ALL, most investigators are still using cranial radiation (CRT) and are hesitant to r
Publikováno v:
Journal of Clinical Oncology. 16:2840-2847
PURPOSE To develop antimetabolite-based consolidation regimens that minimize acute and long-term toxicities and improve the survival rate of children with standard-risk B-lineage acute lymphocytic leukemia (ALL). PATIENTS AND METHODS Seven hundred tw
Autor:
J Pullen, Stephen J. Lauer, Brigid G. Leventhal, Barton A. Kamen, J J Shuster, Andrew J. Carroll, Donald H. Mahoney, C. P. Steuber, G. Kiefer, Bruce M. Camitta
Publikováno v:
Journal of Pediatric Hematology/Oncology. 20:229-233
Purpose: Infants with acute lymphoblastic leukemia (ALL) often enter remission; however, they have a high rate of relapse. To prevent relapse, infants' tolerance of and benefits from early intensive rotating drug pairs as part of therapy were studied
Autor:
Naomi J. Winick, Donald H. Mahoney, Bruce M. Camitta, J J Shuster, R Nitschke, S J Lauer, C P Steuber
Publikováno v:
Journal of Clinical Oncology. 16:246-254
PURPOSE To determine whether early intensification with 12 courses of intravenous methotrexate and intravenous mercaptopurine (IVMTX/IVMP) is superior to 12 courses of repetitive, low-dose oral MTX with I.V. MP (LDMTX/IVMP) for prevention of relapse
Autor:
Sharon B. Murphy, Max J. Coppes, Costan W. Berard, J J Shuster, Martin L. Brecher, Molly R. Schwenn, Michael P. Link, W. Paul Bowman
Publikováno v:
Medical and Pediatric Oncology. 29:526-533
Background The Pediatric Oncology Group (POG) conducted a two-arm, randomized study for the treatment of children and adolescents with stage III small, non-cleaved cell lymphoma (SNCCL). Regimen A, based on the group's previous best treatment for thi
Autor:
M. Hockenberry-Eaton, J. Ochs, D. J. Pullen, Ronald L. Dubowy, C. P. Steuber, Lawrence S. Frankel, Andrew J. Carroll, W. P. Bowman, Michael J. Borowitz, J J Shuster
Publikováno v:
Journal of Pediatric Hematology/Oncology. 19:35-42
Despite improved event-free survival of older children with acute lymphocytic leukemia (ALL), infants1 year of age continue to have a very poor prognosis. A new therapy designed specifically for infants with ALL was initiated.From 1984 until 1990, 82